DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bempegaldesleukin
Bempegaldesleukin
Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer
NKTR-214) (Co-Develop and Co-Promote) NKTR-358 (Co-Promote) NKTR-181 (Wholly-Owned) CD122-Preferential IL-2 T Regulatory Cell New Opioid Agonist Pathway Agonist
Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer
AR-Targeted Agents in Prostate Cancer
2019 Cowen Healthcare Conference
Modulation of CD4 T Cell Response According to Tumor Cytokine Microenvironment
Novel Approaches in Advanced Prostate Cancer
New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?
Nektar Therapeutics
Top View